FY2025 EPS Estimates for REGN Raised by Cantor Fitzgerald
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) – Investment analysts at Cantor Fitzgerald lifted their FY2025 EPS estimates for shares of Regeneron Pharmaceuticals in a report issued on Wednesday, April 30th. Cantor Fitzgerald analyst C. Gould now anticipates that the biopharmaceutical company will post earnings of $26.88 per share for the year, up from their […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) – Investment analysts at Cantor Fitzgerald lifted their FY2025 EPS estimates for shares of Regeneron Pharmaceuticals in a report issued on Wednesday, April 30th. Cantor Fitzgerald analyst C. Gould now anticipates that the biopharmaceutical company will post earnings of $26.88 per share for the year, up from their […]
